Optimal Lipophilicity of Sulfonium <i>p</i>-Toluenesulfonate as Anti-allergic Drug
-
- Tada Yukio
- Open Innovation Center for Drug Discovery, The University of Tokyo
-
- Yamawaki Ichiro
- Biological Laboratory, Taiho Pharmaceutical Company, Ltd.
-
- Ueda Shuichi
- Biological Laboratory, Taiho Pharmaceutical Company, Ltd.
-
- Matsumoto Hiroshi
- Biological Laboratory, Taiho Pharmaceutical Company, Ltd.
-
- Matsuura Naosuke
- Biological Laboratory, Taiho Pharmaceutical Company, Ltd.
-
- Yasumoto Mitsugi
- Biological Laboratory, Taiho Pharmaceutical Company, Ltd.
-
- Koda Akihide
- Gifu Pharmaceutical University
-
- Hori Mikio
- Gifu Pharmaceutical University
Bibliographic Information
- Other Title
-
- スルホニウム <i>p</i> -トルエンスルホン酸誘導体の抗アレルギー薬としての最適疎水性
Description
In the development of the anti-allergic drug Suplatast Tosilate (IPD-1151T) we have reported the QSAR analysis using only the calculated π values, because the few logK values of sulfonium compounds had been measured till then. In this study, we measured the logKTLC value of sulfonium compounds by using octylsililated silicagel plate (Merck HPTLC RP-8 F254S). The logKTLC values of the optimized compounds 52 and 67 (Suplatast Tosilate) of dimethylsulfonium p-toluenesulfonates derivatives were 0.07 and 0.06, respectively. Therefore, it was found that the desirable logKTLC value of the sulfonium compound was approximately zero as the anti-allergic drug.
Journal
-
- Chem-Bio Informatics Journal
-
Chem-Bio Informatics Journal 12 (0), 25-38, 2012
Chem-Bio Informatics Society
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282680081019648
-
- NII Article ID
- 130004054116
-
- ISSN
- 13470442
- 13476297
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed